Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA

INTRODUCTION: Anti-cyclic citrullinated peptide (anti-CCP) antibodies are associated with poor prognosis in patients with rheumatoid arthritis (RA). Previous data from randomized controlled trials and clinical practice have shown anti-CCP-positive (+) patients had a better response to treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., Bryson, Joshua, Lehman, Thomas, Zhuo, Joe, Gao, Sheng, Han, Xue, Schrader, Amy, Rebello, Sabrina, Pappas, Dimitrios A., Sommers, Tanya, Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217398/
https://www.ncbi.nlm.nih.gov/pubmed/34047953
http://dx.doi.org/10.1007/s40744-021-00310-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217398/
https://www.ncbi.nlm.nih.gov/pubmed/34047953
http://dx.doi.org/10.1007/s40744-021-00310-2

Ejemplares similares